SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Taneja Hemant

(Last) (First) (Middle)
20 UNIVERSITY ROAD, 4TH FLOOR

(Street)
CAMBRIDGE MA 02138

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Teladoc Health, Inc. [ TDOC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
04/19/2021
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 04/19/2021 S(1) 1,200 D $181.709(2) 142,560 D
Common Stock 04/19/2021 S(1) 8,266 D $182.672(3) 134,294 D
Common Stock 04/19/2021 S(1) 3,000 D $183.434(4) 131,294 D
Common Stock 04/19/2021 S(1) 1,900 D $184.582(5) 129,394 D
Common Stock 04/19/2021 S(1) 900 D $185.69(6) 128,494 D
Common Stock 04/19/2021 S(1) 1,100 D $186.776(7) 127,394 D
Common Stock 04/19/2021 S(1) 1,934 D $188.012(8) 125,460 D
Common Stock 04/19/2021 S(1) 2,122 D $189.092(9) 123,338 D
Common Stock 04/19/2021 S(1) 4,278 D $189.803(10) 119,060 D
Common Stock 04/19/2021 S(1) 300 D $190.693(11) 118,760 D
Common Stock 5,256,977 I See footnote(12)
Common Stock 373,361 I See footnote(13)
Common Stock 1,090,622 I See footnote(14)
Common Stock 3,391 I See footnote(15)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. These transactions were effected pursuant to a Rule 10b5-1 trading plan.
2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $181.04 to $182.00, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (11) of this Form 4.
3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $182.05 to $183.03, inclusive.
4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $183.06 to $183.97, inclusive.
5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $184.13 to $184.99, inclusive.
6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $185.24 to $186.13, inclusive.
7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $186.32 to $187.17, inclusive.
8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $187.32 to $188.28, inclusive.
9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $188.43 to $189.39, inclusive.
10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $189.42 to $190.37, inclusive.
11. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $190.50 to $190.80, inclusive.
12. The shares are held of record by General Catalyst Group VI, L.P., or GC Group VI LP. General Catalyst GP VI, LLC, or GP VI LLC, is the general partner of General Catalyst Partners VI, L.P., which is the general partner of GC Group VI LP. General Catalyst Group Management Holdings, L.P., or GCGMH, is the manager of General Catalyst Group Management, LLC, or GCGM, which is the manager of GP VI LLC. As a Managing Member of General Catalyst Group Management Holdings GP, LLC, or GCGMH LLC, the general partner of GCGMH, the reporting person shares voting and investment power with respect to shares held by GC Group VI LP. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in such securities.
13. 10,616 shares are held by 7wire Investment Holdings, Ltd., or 7wire, which is wholly owned by General Catalyst Group VIII, L.P., or GC Group VIII LP, and the balance are held by GC Group VIII LP. General Catalyst GP VIII, LLC, or GP VIII LLC, is the general partner of General Catalyst Partners VIII, L.P., or GP VIII LP, which is the general partner of GC Group VIII LP. GCGM, is the manager of GP VIII LLC. GCGMH, is the manager of GCGM. As a Managing Member of GCGMH LLC, the general partner of GCGMH, the reporting person shares voting and investment power with respect to shares held by 7wire and GC Group VIII LP. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in such securities.
14. The shares are held of record by General Catalyst Group VIII Supplemental, L.P., or GC Group VIII Supplemental. GP VIII LLC is the general partner of GP VIII LP, which is the general partner of GC Group VIII Supplemental. GCGMH is the manager of GCGM, which is the manager of GP VIII LLC. As a Managing Member of GCGMH LLC, the general partner of GCGMH, the reporting person shares voting and investment power with respect to shares held by GC Group VIII Supplemental. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in such securities.
15. These shares are held of record by GCGM Investment Holdings, LP, or GCGM IH. As a Managing Member of GCGMH LLC, the general partner of GCGM IH, the reporting person shares voting and investment power with respect to shares held by GCGM IH. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest in such securities.
/s/ Christopher McCain, attorney-in-fact for Hemant Taneja 04/21/2021
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.